Skip to main content
Cancers logoLink to Cancers
. 2016 Apr 7;8(4):44. doi: 10.3390/cancers8040044

Expression of Concern: Takai, N. and Narahara, H. Epigenetic Therapy in Human Choriocarcinoma. Cancers 2010, 2, 1683–1688

Cancers Editorial Office1
Editor: Samuel C Mok1
PMCID: PMC4846853

We wish to make readers aware that text in [1] has been taken from other publications by the same author. In particular, much of Section 1, the first part of Section 2 and the first sentence of Section 3 are copied verbatim from [2]. Table 1 and the second part of Section 2 are taken from [3]. The main novel contribution of [1] lies in Section 3. We regret that these issues were not picked up before publication and wish to apologize to readers of Cancers.

References

  • 1.Takai N., Narahara H. Epigenetic therapy in human choriocarcinoma. Cancers. 2010;2:1683–1688. doi: 10.3390/cancers2031683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Takai N., Narahara H. Histone deacetylase inhibitor therapy in epithelial ovarian cancer. J. Oncol. 2010;2010:458431. doi: 10.1155/2010/458431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Takai N., Narahara H. Preclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancer. Obstet. Gynecol. Int. 2010;2010:923824. doi: 10.1155/2010/923824. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancers are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES